| RS1775514576 |
RSPH4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1775529306 |
MAK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1775537467 |
CEP85L
|
Health Risk |
Pathogenic |
Lissencephaly 10, Posterior Predominant Lissencephaly |
| RS1775537638 |
CEP85L
|
Health Risk |
Likely pathogenic |
Posterior Predominant Lissencephaly, Posterior Predominant Lissencephaly |
| RS1775546363 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS1775559365 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 43 |
| RS1775590631 |
HIVEP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1775596006 |
PERP
|
Health Risk |
Pathogenic |
Erythrokeratodermia variabilis et progressiva 7, Erythrokeratodermia variabilis et progressiva 7 |
| RS1775596924 |
PERP
|
Health Risk |
Pathogenic |
Olmsted syndrome 2, Olmsted syndrome 2 |
| RS1775596990 |
PERP
|
Health Risk |
Pathogenic |
Olmsted syndrome 2, Olmsted syndrome 2 |
| RS1775623278 |
HIVEP2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 43 |
| RS1775638556 |
MYO6
|
Health Risk |
Likely pathogenic |
— |
| RS1775719317 |
RSPH4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental delay, Primary ciliary dyskinesia |
| RS1775758975 |
RSPH4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1775769921 |
RFX6
|
Health Risk |
Likely pathogenic |
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome, Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome |
| RS1775776645 |
RSPH4A
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1775783657 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1775821411 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1775850515 |
FIG4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4J, Charcot-Marie-Tooth disease type 4J |
| RS1775923311 |
EPM2A
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1775958137 |
MYO6
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 22, Autosomal dominant nonsyndromic hearing loss 22 |
| RS1775982467 |
MED23
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 18 |
| RS1775984639 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS1775986353 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1775988406 |
CYP21A2
|
Health Risk |
Pathogenic/Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1775996165 |
CYP21A2
|
Health Risk |
Pathogenic |
— |
| RS1776055887 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
— |
| RS1776070919 |
CYP21A2
|
Health Risk |
Likely pathogenic |
— |
| RS1776095671 |
CYP21A2
|
Health Risk |
Pathogenic |
— |
| RS1776123817 |
CYP21A2
|
Health Risk |
Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1776147010 |
TUBB
|
Health Risk |
Likely pathogenic |
Multiple benign circumferential skin creases on limbs 1, Multiple benign circumferential skin creases on limbs 1 |
| RS1776174152 |
MED23
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1776193326 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1776199533 |
MAP3K7
|
Health Risk |
Pathogenic |
Cardiospondylocarpofacial syndrome, Cardiospondylocarpofacial syndrome |
| RS1776217797 |
CYP21A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1776224762 |
FIG4
|
Health Risk |
Pathogenic |
— |
| RS1776234662 |
CYP21A2
|
Health Risk |
Pathogenic/Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1776240589 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1776275893 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS1776276356 |
ZBTB24
|
Health Risk |
Likely pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS1776278098 |
TNFAIP3
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS1776281365 |
CCN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS1776281475 |
CCN6
|
Health Risk |
Pathogenic |
— |
| RS1776290442 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS1776309065 |
CYP21A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1776314873 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1776315132 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1776319116 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1776320682 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1776322078 |
KCNQ5
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 46 |
| RS1776322102 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1776323909 |
CYP21A2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1776331041 |
TNFAIP3
|
Health Risk |
Pathogenic |
— |
| RS1776339162 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1776361528 |
TUBB
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 6, Complex cortical dysplasia with other brain malformations 6 |
| RS1776373606 |
ACSF3
|
Health Risk |
Pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1776393502 |
FIG4
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 11, Amyotrophic lateral sclerosis type 11 |
| RS1776395738 |
TUBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1776399868 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS1776402708 |
ZBTB24
|
Health Risk |
Likely pathogenic |
— |
| RS1776405797 |
TRDN
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1776423674 |
RTN4IP1
|
Health Risk |
Pathogenic |
— |
| RS1776430407 |
TUBB
|
Health Risk |
Likely pathogenic |
— |
| RS1776459285 |
TUBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1776463168 |
MAP3K7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1776478413 |
TUBB
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 6, Complex cortical dysplasia with other brain malformations 6 |
| RS1776514016 |
CCN6
|
Health Risk |
Pathogenic |
— |
| RS1776515103 |
RTN4IP1
|
Health Risk |
Likely pathogenic |
— |
| RS1776518694 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1776627236 |
CCN6
|
Health Risk |
Likely pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS1776631188 |
CCN6
|
Health Risk |
Likely pathogenic |
— |
| RS1776635075 |
CCN6
|
Health Risk |
Pathogenic |
— |
| RS1776708773 |
MAK
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1776708973 |
MAK
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 62, Retinitis pigmentosa 62 |
| RS1776730034 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1776734650 |
RTN4IP1
|
Health Risk |
Pathogenic |
— |
| RS1776735394 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1776744347 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1776744623 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1776761448 |
CCN6
|
Health Risk |
Pathogenic |
— |
| RS1776788274 |
EPM2A
|
Health Risk |
Pathogenic |
Lafora disease, Lafora disease |
| RS1776791266 |
EPM2A
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1776805400 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS1776808199 |
CCN6
|
Health Risk |
Pathogenic |
— |
| RS1776810581 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS1776817138 |
EPM2A
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1776911945 |
MAP3K7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiospondylocarpofacial syndrome, Cardiospondylocarpofacial syndrome |
| RS1776941586 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1776944236 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 5 |
| RS1776950897 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Muscular dystrophy |
| RS1776953529 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1776953853 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1776964566 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related disorder, LAMA2-related disorder |
| RS1777036380 |
GTF2H5
|
Health Risk |
Pathogenic |
Trichothiodystrophy 3, photosensitive |
| RS1777038679 |
GTF2H5
|
Health Risk |
Pathogenic |
Trichothiodystrophy 3, photosensitive |
| RS1777047446 |
QRSL1
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 40, Combined oxidative phosphorylation deficiency 40 |
| RS1777073184 |
MYO6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1777174302 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1777175608 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1777196665 |
SYNGAP1
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Inborn genetic diseases |